Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS: ENZN · Delayed Price · USD
0.0750
0.00 (0.00%)
May 3, 2024, 9:30 AM EDT - Market closed

Enzon Pharmaceuticals Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.57M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 202226.00K-675.00K-96.29%
Dec 31, 2021701.00K649.00K1,248.08%
Dec 31, 202052.00K-155.00K-74.88%
Dec 31, 2019207.00K-6.71M-97.01%
Dec 31, 20186.92M-1.46M-17.44%
Dec 31, 20178.38M2.00K0.02%
Dec 31, 20168.38M-9.08M-52.01%
Dec 31, 201517.46M-13.72M-44.00%
Dec 31, 201431.17M-3.32M-9.63%
Dec 31, 201334.49M-8.11M-19.03%
Dec 31, 201242.60M-5.47M-11.38%
Dec 31, 201148.07M-49.79M-50.88%
Dec 31, 201097.87M-86.76M-46.99%
Dec 31, 2009184.62M-12.32M-6.25%
Dec 31, 2008196.94M11.34M6.11%
Dec 31, 2007185.60M-52.00K-0.03%
Dec 31, 2006185.65M--
Dec 31, 20050--
Jun 30, 2005169.57M23.17M15.82%
Jun 30, 2003146.41M70.60M93.14%
Jun 30, 200275.80M44.22M139.98%
Jun 30, 200131.59M14.57M85.62%
Jun 30, 200017.02M3.82M28.92%
Jun 30, 199913.20M-1.40M-9.59%
Jun 30, 199814.60M1.90M14.96%
Jun 30, 199712.70M--
Jun 30, 199612.70M-3.10M-19.62%
Jun 30, 199515.80M1.00M6.76%
Jun 30, 199414.80M6.40M76.19%
Jun 30, 19938.40M2.70M47.37%
Jun 30, 19925.70M3.30M137.50%
Jun 30, 19912.40M-100.00K-4.00%
Jun 30, 19902.50M-200.00K-7.41%
Jun 30, 19892.70M2.40M800.00%
Jun 30, 1988300.00K200.00K200.00%
Jun 30, 1987100.00K--
Jun 30, 1986100.00K--
Jun 30, 19850--
Jun 30, 19840--
Jun 30, 19830--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 371.62B
Johnson & Johnson 81.80B
Merck & Co. 60.12B
AbbVie 54.32B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.86B
Abbott Laboratories 40.33B
Revenue Rankings